Spinal biologics are an important component of lumbar interbody spine fusion. Biologics are substances that work to alter the local environment by affecting cellular activity, growth, and differentiation through inherent properties of osteogenesis, osteoinduction, and osteoconduction.
This report contains market size and forecasts of Spinal Fusion Biologics in global, including the following market information:
Global Spinal Fusion Biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Spinal Fusion Biologics Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Spinal Fusion Biologics companies in 2021 (%)
The global Spinal Fusion Biologics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bone Graft Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Spinal Fusion Biologics include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, Zimmer Biomet, Stryker, Straumann, Wright Medical Group and Hans Biomed and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Spinal Fusion Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Spinal Fusion Biologics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Spinal Fusion Biologics Market Segment Percentages, by Type, 2021 (%)
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Global Spinal Fusion Biologics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Spinal Fusion Biologics Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Spinal Fusion Biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Spinal Fusion Biologics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Spinal Fusion Biologics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Spinal Fusion Biologics revenues share in global market, 2021 (%)
Key companies Spinal Fusion Biologics sales in global market, 2017-2022 (Estimated), (Units)
Key companies Spinal Fusion Biologics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex